Close Menu

NEW YORK − Kinnate Biopharma said on Wednesday that it has raised $98 million in a Series C financing round led by RA Capital Management.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.